Immunohistochemical analysis of the tumours in the SW480-grafted mice revealed that the cellular level of phosphorylated PKD was markedly reduced by ZPT administration in a dose-dependent manner, supporting the inhibition of the PLCε-mediated signaling (Fig. 6D). Here, PRKD1 is linked to neoplasm.